New York, NY, January 11, 2009 --(PR.com
)-- ScyFIX, a privately held company that distributes eye therapy products, announced today that it will participate in the OneMedPlace Finance Forum in San Francisco, CA from January 13-14, 2009. Thomas W. Harold, Founder, Chief Executive Officer of ScyFIX, will present on Tuesday, January 13th at 11:45 a.m. Pacific Time, at the Sir Francis Drake Hotel at 450 Powell St. Information about the OneMedPlace Finance forum may be found at www.onemedplace.com.
ScyFIX is a multi-national company based in Minneapolis, Minnesota USA, that distributes eye therapy products using micro current stimulation, which we consider to be the most effective available treatment for Macular Degeneration and other degenerative eye diseases.
ScyFIX develops sight-saving technologies for people suffering from degenerative eye diseases for which there are currently no cures or therapies. ScyFIX offers the only patented micro-current stimulation device for the treatment of macular degeneration, Stargardt's disease, retinitis pigmentosa and other degenerative eye diseases. For more information, visit www.scyfix.org or contact the company at 612-964-6500.
About OneMedPlace: OneMedPlace is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine—emerging companies and technologies seeking capital, distribution, visibility and resources to help finance, build and grow, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.